News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Ruzanna Papyan: Empower AYAs for a healthier future!
Photo of Shushan Hovsepyan taken from Ruzanna Papyan/X
Feb 6, 2024, 16:55

Ruzanna Papyan: Empower AYAs for a healthier future!

Ruzanna Papyan, Pediatric Oncologist at the Pediatric Cancer and Blood Disorders Center of Armenia, shared on X/Twitter:

“Empower AYAs for a healthier future! Prioritize communication, mental health, and inclusive care. Thank you Shushan Hovsepyan for the insightful talk.”

Source: Ruzanna Papyan/X

AYA care cancer global health OncoDaily Oncology patient care Pediatric Cancer and Blood Disorders Center of Armenia Ruzanna Papyan Shushan Hovsepyan
Blog
Jul 5, 2024, 17:50
First-of-its-kind PhD program in cancer engineering - MSKCC
Blog
Jul 5, 2024, 17:27
Julie Ross shares the story of her career journey with OncoDaily - Advanced Clinical
Insight
Jul 5, 2024, 16:59
Pat Price: As we approach the general election, cancer must be a top priority for our new Government
Blog
Jul 5, 2024, 16:32
July edition of the IAPC's newsletter
Blog
Jul 5, 2024, 16:31
Fumiko Ladd Chino: I strongly support Dr Neha Vapiwala for President at ASTRO
Insight
Jul 5, 2024, 16:30
CAR NK cells with CD28 costimulation improved cell persistence and antitumor activity
Blog
Jul 5, 2024, 16:21
Latest episodes from the Precision Medicine podcast
Insight
Jul 5, 2024, 16:12
Sunscreen Is Your Best Friend This Summer - Sylvester Cancer Experts
Drugs
Jul 5, 2024, 15:53
Gevorg Tamamyan: Waiting too see promising bot/bal results from our lung cancer trial
Insight
Jul 5, 2024, 15:41
Development of an EORTC QoL module for patients with advanced melanoma
Blog
Jul 5, 2024, 15:32
Gemma Peters: The new government has an opportunity to fix our broken cancer care system
Drugs
Jul 5, 2024, 15:03
Andrea Apolo: Phase 1 study of Cabozantinib, Nivolumab, and Ipilimumab for genitourinary tumours